Hidden M&A Risks: What Volunteering as Shareholder Representative Could Cost You

When a private company is sold, someone has to manage the post-closing process on behalf of the selling shareholders. In some transactions, a founder, lead investor, or former executive volunteers to take on this role—often because it is what seems easiest.

What these well-intentioned volunteers frequently underestimate is the scope of risk they are assuming. The role of shareholder representative—sometimes called a seller representative—carries personal, legal, and financial exposure that can persist for years after closing. And once the commitment is made, it is not easily unwound.

This article outlines the specific risks that arise when an individual or entity volunteers to serve as shareholder representative and explains why a growing number of deal makers are concluding that the smartest approach is to engage a professional.

Legal and Liability Risks

• Personal litigation exposure 
• Fiduciary duties and duty of care 
• Conflicts of interest 
• Not covered by insurance

Expertise and Compliance Risks

• Pro rata calculations 
• Capitalization claims (and other post-closing matters) 
• Custodian of seller funds

Time and Effort Risks

• Unpredictable time commitment 
• Administrative complexity

The Risks of Volunteering as Shareholder Representative

The following risks are not hypothetical. They arise regularly in private M&A transactions and can have material consequences for the individuals who assume this role.

Personal Litigation Exposure

Serving as shareholder representative is one of the few roles in which a person can be personally named in litigation, despite having done nothing wrong. If a buyer brings an indemnification claim under the acquisition agreement that cannot be resolved informally, the representative—not all the individual selling shareholders—is typically the named defendant. Being a party to a lawsuit carries consequences well beyond legal fees: It can impair the individual’s ability to obtain credit or insurance, create disclosure obligations, and consume significant time and attention over a period of months or years.

About three out of ten private-target acquisitions suffer a post-closing indemnification claim, and at least as many deals with an earnout see a dispute.

Source: 2024 SRS Acquiom M&A Claims Insights Report

Fiduciary Duties and Duty of Care

Most courts treat the representative as an agent for the selling shareholders, often with legal obligations and duties and potentially resulting in personal liability. If the representative is found to have failed to meet the applicable duty of care—whether through inaction, a missed deadline, or a judgment call that disadvantages certain shareholders—the representative may be held personally liable for resulting damages. Many merger agreements provide that if the shareholder representative fails to respond to an indemnity claim notice within a specified period, the claim is deemed accepted. A single missed deadline could have significant financial consequences for the selling shareholders and expose the representative to claims of negligence.

Conflicts of Interest

A volunteer representative who continues to work for the acquired company after closing faces an inherent tension: Advocating for the former shareholders may put the representative at odds with a new employer. Even where the representative has no ongoing relationship with the buyer, differences in liquidation preferences, economic interests, or risk tolerance among the selling shareholders can create conflicts. The protections typically afforded to corporate directors under the business judgment rule may not extend to a shareholder representative whose economic interests diverge from those of the shareholders the representative is charged with protecting. On a related note, well-established professional shareholder representatives often build cordial working relationships with M&A buyers, adding efficiency and reducing costs when resolving post-closing matters.

Not Covered by Insurance

Unlike corporate directors and officers, the shareholder representative generally cannot obtain insurance for this role. Direct and Officers (D&O) policies and tail coverage typically do not apply. The representative bears the full weight of personal exposure without a safety net.

Pro Rata Calculations and Capitalization Claims

Capitalization tables on private-target M&A are growing longer and more complicated with respect to liquidation preferences and contracted returns.

Indemnification claims for breach of the capitalization representative were the third most common (after taxes and undisclosed liabilities).

Source: 2024 SRS Acquiom M&A Claims Insights Report

Additionally, the shareholder representative is often saddled with calculating post-closing distributions, which are common in private-target transactions because of escrow releases, working capital adjustments, and earnouts. These calculations may be a one-two punch for the shareholder representative:

• First, the pro rata may need to be re-calculated as payments are made on the deal;
• Second, the individual payment amounts, tax characterizations, and other details must be calculated, compiled, and delivered to the paying agent.

Custodian of Seller Funds

Private-target M&A deals often include an “expense fund” established by the sellers to cover any post-closing expenses or defend against claims. The shareholder representative must open a bank account, hold, manage, and account for such funds—not to mention distribute any remainder to the other sellers. The shareholder representative is often a party to ancillary agreements requiring them to clear anti-money laundering disclosures—also known as KYC (know your customer) or CDD (customer due diligence)—and other account opening requirements.

Unpredictable Time Commitment

Post-closing obligations can extend for years and arise without warning. Working capital adjustments, indemnification claims, earnout disputes, tax filings for stub periods, voluntary disclosure agreements with local and state taxing authorities, shareholder inquiries, subpoenas, transfers of interest, and buyer bankruptcy proceedings are just some of the issues that may land on the representative’s desk. For individuals who have moved on to new roles or investments, these obligations can quickly become a significant distraction from their primary professional responsibilities.

Nine out of 10 deals have a potential for a post-closing distribution, whether that is an escrow release (median survival period is 12 months) or potential milestone payment (median performance period is 21 months and more than 10% are longer than four years).

Source: 2026 SRS Acquiom M&A Deal Terms Study

Administrative Complexity

Beyond disputes, the representative is responsible for a demanding set of administrative tasks: tracking each shareholder’s pro rata interest, distributing periodic statements, ensuring accurate tax withholding, managing escrow and earnout payment calculations, and maintaining records across what may be a large and complex capitalization table—not to mention fielding questions from multiple selling shareholders across several time zones. These tasks require infrastructure and systems that most individuals and small firms simply do not have.

Why Forming a New Entity Does Not Solve the Problem

Some individuals named as shareholder representative might attempt to mitigate personal exposure by forming a special-purpose entity to serve as the legal named shareholder representative. In practice, this approach creates more problems than it solves. Establishing the entity is time-consuming and expensive. After closing, the entity must file annual reports and tax returns and eventually be wound down. More fundamentally, certain claims could still expose the individuals behind the new entity to personal liability, raising questions about whether the entity structure would provide meaningful legal protection in all circumstances. And the core problem remains: someone must still do the work, absorb the time commitment, and take responsibility for the outcomes.

The Alternative: Control Without the Risk

Engaging a professional shareholder representative allows selling shareholders to shed the risks outlined above while retaining control over post-closing decisions. A professional shareholder representative is an independent entity that assumes the role—and the associated exposure—on behalf of the sellers. The shareholder representative takes its direction from the sellers.

In a typical engagement, an advisory committee of key former shareholders is established to provide direction on significant matters. In practice, the professional representative is a consortium of legal, accounting, and tax experts, all drawing from the experience of solving problems, resolving claims, and managing the day-to-day administrative work across thousands of transactions. The shareholders decide the level of involvement they want on each category of post-closing issues. The result is a structure that eliminates personal risk, ensures expert management of the process, and preserves the sellers’ decision-making authority where it matters most.

Key Takeaways

• Volunteering as shareholder representative exposes individuals to personal litigation risk, fiduciary liability, conflicts of interest, and an unpredictable multi-year time commitment—with no available insurance coverage.
• These risks are not theoretical. They arise regularly and can have material financial and professional consequences.
• A professional shareholder representative assumes these risks while allowing the selling shareholders to retain control over the decisions that matter most.

The question is not whether an individual is able to serve as shareholder representative, but rather, can they weather the storm of shareholder communications, pro rata calculations, claims, tax filings, working capital adjustments, and more that are common on private-target M&A deals—all without incurring any personal liability?

A professional shareholder representative can not only assume risk but also create better outcomes. SRS Acquiom pioneered this role and has served as shareholder representative on thousands of transactions as the industry leader. That depth of experience translates into protected escrows, faster claim resolution, convenience for shareholders, and the ability to anticipate problems before they materialize. M&A buyers also benefit from the speed and efficiency experienced professional shareholder representatives provide, particularly serial buyers that often develop strong, ongoing working relationships with those professionals.

Learn more about how SRS Acquiom can support your professional shareholder representative needs.